Press Releases Shield Therapeutics plc

Equities

Market Closed - London S.E. Other stock markets 11:35:08 2024-05-01 am EDT			5-day change	1st Jan Change
1.75 ^GBX	+29.63%		+22.81%	-73.88%

Apr. 30	EARNINGS AND TRADING: Software Circle & Beximco report higher revenue	AN
Apr. 30	Transcript : Shield Therapeutics plc, 2023 Earnings Call, Apr 30, 2024

Hardman & Co Research on Shield Therapeutics (STX): Accelerating effectiveness of enlarged sales team	Nov. 15	EQ
Shield to Present Abstract at 26th Annual Women's Healthcare Conference 2023 on Accrufer	23-10-23	AQ
Shield Therapeutics' pricing will be "key metric" - Proactive Research Analyst	23-10-05	AQ
Shield Therapeutics "couldn't be more pleased" with Viatris collaboration	23-10-05	AQ
Shield Therapeutics : Launch Announcement	23-09-28	PU
Proactive Research Analyst says Shield Therapeutics' commercialisation drive "going well"	23-08-01	AQ
Shield Therapeutics "really starting to fire on all cylinders"	23-07-25	AQ
Shield Therapeutics : Notice of Annual General Meeting 2023	23-05-19	PU
Shield Therapeutics : 2022 Annual Report and Accounts	23-05-19	PU
Shield Therapeutics : Letter to Shareholders	23-05-19	PU
Premier Miton Group Plc - Form 8.3 - Shield Therapeutics plc	23-05-09	PR
Form 8.3 - Shield Therapeutics plc	23-05-09	AQ
Killik & Co. LLP - Form 8.3 - Shield Therapeutics Plc	23-05-09	PR
Killik & Co. LLP - Form 8.3 - Shield Therapeutics Plc	23-05-05	PR
Shield Therapeutics : Rule 2.11 Letter to Employees	23-05-04	PU
Shield Therapeutics plc - Appointment of Chief Commercial Officer	23-04-06	AQ
Proactive research analyst says Shield Therapeutics "in fast growth mode"	23-02-13	AQ
Shield Therapeutics "ended 2022 in a very very productive state"	23-02-13	AQ
Shield Therapeutics plc - Full Year Trading Update	23-02-10	AQ
Shield Therapeutics plc - Publication of Circular & Notice of General Meeting	22-12-19	AQ

No results for this search